Tetraphase Pharmaceu
(TTPH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2015 | 12-2014 | 09-2014 | 06-2014 | 03-2014 | |
| Sales | 3,016 | 3,072 | 2,294 | 1,275 | 2,457 |
| Gross Profit | 3,016 | 3,072 | 2,294 | 1,275 | 2,457 |
| Operating Expenses | 23,776 | 23,455 | 16,274 | 19,460 | 15,675 |
| Operating Income | -20,760 | -20,383 | -13,980 | -18,185 | -13,218 |
| Interest Expense | 0 | 683 | 0 | 0 | 334 |
| Other Income | -226 | 516 | -226 | -278 | 29 |
| Pre-tax Income | -20,986 | -20,550 | -14,206 | -18,463 | -13,523 |
| Net Income Continuous | -20,986 | -20,550 | -14,206 | -18,463 | -13,523 |
| Net Income | $-20,986 | $-20,550 | $-14,206 | $-18,463 | $-13,523 |
| EPS Basic Total Ops | -13.20 | -14.00 | -11.00 | -14.20 | -10.60 |
| EPS Basic Continuous Ops | -13.22 | -14.06 | -10.94 | -14.29 | -10.51 |
| EPS Diluted Total Ops | -13.20 | -14.00 | -11.00 | -14.20 | -10.60 |
| EPS Diluted Continuous Ops | -13.22 | -14.06 | -10.94 | -14.29 | -10.51 |
| EBITDA(a) | $-20,635 | $-20,310 | $-13,888 | $-18,095 | $-13,123 |